Delavirdine mesylate - CAS 147221-93-0
Catalog number: 147221-93-0
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C23H32N6O6S2
Molecular Weight:
552.67
COA:
Inquire
Targets:
HIV
Description:
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV) type 1.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Rescriptor; U 90152
MSDS:
Inquire
1. Clinical Implications of CNS Penetration of Antiretroviral Drugs
Heather E. Wynn, Richard C. Brundage and Courtney V. Fletcher. CNS Drugs 2002; 16 (9): 595-609
Delavirdine mesylate, nevirapine and efavirenz are the three currently marketed NNRTIs. As mentioned in section 2, the plasma protein binding of this class of agents varies, from>95%for delavirdine mesylate and efavirenz to approximately 60% for nevirapine. There are limited published data on the CSF penetration of this class of compounds (table II). Of the three available NNRTIs, delavirdine mesylate is the least often used in routine clinical practice because of its inconvenient administration schedule and toxicity profile. The available clinical data on CSF penetration focus on nevirapine and efavirenz. In clinical studies, both nevirapine and efavirenz are detected in the CSF up to 20 hours postdose as a result of their long elimination half-lives. For both antivirals, the CSF concentrations are variable and display a time-dependent decrease. In contrast, the CSF-to-plasma concentration ratios increase over the duration of the dose interval, a reflection of faster elimination from the central compartment.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HIV Products


CAS 35943-35-2 Triciribine

Triciribine
(CAS: 35943-35-2)

Triciribine is a potent AKT inhibitor and a cell-permeable tricyclic nucleoside molecule with potential antineoplastic activity. Akt-1, -2, and -3 are serine/th...

CAS 202138-50-9 Tenofovir Disoproxil Fumarate

Tenofovir Disoproxil Fumarate
(CAS: 202138-50-9)

Tenofovir Disoproxil Fumarate belongs to a class of antiretroviral drugs, it inhibits the activity of HIV reverse transcriptase by competing with the natural su...

CAS 544467-07-4 HIV-1 integrase inhibitor

HIV-1 integrase inhibitor
(CAS: 544467-07-4)

HIV-1 integrase inhibitor is uesful for anti-HIV, which can target HIV-1 integrase and depress the activity in the treatment of HIV infection, AIDS, and other s...

CAS 134678-17-4 Lamivudine

Lamivudine
(CAS: 134678-17-4)

Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor, used for treatment of chronic HBV and HIV/AIDS.

CAS 192725-17-0 Lopinavir

Lopinavir
(CAS: 192725-17-0)

Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM.

CAS 159989-65-8 Nelfinavir Mesylate

Nelfinavir Mesylate
(CAS: 159989-65-8)

Nelfinaviris a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor.

CAS 69655-05-6 Didanosine

Didanosine
(CAS: 69655-05-6)

Didanosine is a reverse transcriptase inhibitor with an IC50 of 0.49 μM.

CAS 226700-81-8 Fosamprenavir Calcium Salt

Fosamprenavir Calcium Salt
(CAS: 226700-81-8)

HIV protease inhibitor; water soluble prodrug of amprenavir.

CAS 729607-74-3 BMS-707035

BMS-707035
(CAS: 729607-74-3)

BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM.

CAS 157810-81-6 Indinavir sulfate

Indinavir sulfate
(CAS: 157810-81-6)

Indinavir is a protease inhibitor used as a component of highly active antiretroviral therapy to treat HIV infection and AIDS. It inhibits the HIV-1 protease wi...

CAS 333352-59-3 NBD-557

NBD-557
(CAS: 333352-59-3)

NBD-557 is a N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamide analog, a novel class of human immunodeficiency virus type 1 (HIV-1) entry inhibitors th...

CAS 697761-98-1 Elvitegravir

Elvitegravir
(CAS: 697761-98-1)

Elvitegravir (EVG, JTK-303/GS-9137) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively.

CAS 473921-12-9 Lersivirine

Lersivirine
(CAS: 473921-12-9)

Lersivirine is a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for the treatment of HIV-1 infection. It prevents HIV ...

CAS 143491-57-0 Emtricitabine

Emtricitabine
(CAS: 143491-57-0)

Emtricitabine moderately reduces hepatocyte proliferation independent of effects on mtDNA in HepG2 human hepatoma cells.

CAS 957890-42-5 HIV-1 integrase inhibitor 2

HIV-1 integrase inhibitor 2
(CAS: 957890-42-5)

HIV-1 integrase inhibitor 2 is useful for anti-HIV, which can target HIV-1 integrase and depress the activity in the treatment of HIV infection, AIDS, and other...

CAS 206184-49-8 Tenofovir hydrate

Tenofovir hydrate
(CAS: 206184-49-8)

Tenofovir(GS 1278, PMPA) is an antiretroviral drug known as nucleotide analogue reverse transcriptase inhibitors (NRTIs), which block reverse transcriptase, a c...

CAS 161814-49-9 Amprenavir

Amprenavir
(CAS: 161814-49-9)

Amprenavir promotes the specific interactions between the nuclear receptor pregnane X receptor (PXR) and the coactivators SRC-1 and PBP.

CAS 376348-65-1 Maraviroc

Maraviroc
(CAS: 376348-65-1)

Selective CCR5 antagonist

Ingenol 3-Hexanoate
(CAS: 83036-61-7)

Ingenol 3-Hexanoate, an ingenol-derived compound, was more potent in reactivating latent HIV than other known activators such as SAHA, ingenol 3,20-dibenzoate, ...

CAS 1415559-43-1 CDK9-IN-1

CDK9-IN-1
(CAS: 1415559-43-1)

Among CDKs, CDK9 is a validated pathological target in HIV infection, inflammation and cardiac hypertrophy; however selective CDK9 inhibitors are still not avai...

Chemical Structure

CAS 147221-93-0 Delavirdine mesylate

Quick Inquiry

Verification code

Featured Items